ArticleInternational journal of hematology2012

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma.

Asher A Chanan-Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.